Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Energy-based Therapeutics
... CAGR of 3.6% over the analysis period 2024-2030. Laser-based Technology, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Allergy Diagnostics
... CAGR of 10.0% over the analysis period 2024-2030. Allergy Diagnostics Assay Kits, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$4.5 Billion by the end of ... Read More
-
Sex Toys
... CAGR of 7.9% over the analysis period 2024-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.8 Billion by the end of the analysis ... Read More
-
Postpartum Hemorrhage (PPH) Treatment Devices
... Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$521.7 ... Read More
-
Clear Aligners
... CAGR of 23.8% over the analysis period 2024-2030. Adult Clear Aligners, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$14.9 Billion by the end of the ... Read More
-
Doxorubicin
... 5.8% over the analysis period 2024-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$374.1 Million by the end of the analysis period. ... Read More
-
Contract Research Organization Services (CROs)
... Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Clinical Research Services, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$76.7 ... Read More
-
CNS Therapeutics
... CAGR of 7.3% over the analysis period 2024-2030. Neurodegenerative Diseases Therapeutics, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$75.9 Billion by the end of the ... Read More
-
Bone Growth Stimulators
... at a CAGR of 4.9% over the analysis period 2024-2030. Stimulation Devices, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$855.7 Million by the end of ... Read More
-
Corporate Wellness
... CAGR of 6.5% over the analysis period 2024-2030. Health Risk Assessment, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$27.9 Billion by the end of the ... Read More
-
Contraceptives
... 6.3% over the analysis period 2024-2030. Contraceptive Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$26.0 Billion by the end of the analysis period. Growth ... Read More
-
Bioprosthetics
... 9.7% over the analysis period 2024-2030. Xenograft, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$8.3 Billion by the end of the analysis period. Growth in ... Read More
-
Isosorbide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... forecast period 2024-2030. North American market for Isosorbide was valued at $ 30.30 million in 2023 and will reach $ 68.92 million by 2030, at a CAGR of 13.55% during the forecast period of 2024 ... Read More
-
Pedicle Screw System
... at a CAGR of 4.0% over the analysis period 2024-2030. Polyaxial Pedicle Screw System, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.6 Billion by the ... Read More
-
Pediatric Imaging
... CAGR of 7.1% over the analysis period 2024-2030. Magnetic Resonance Imaging, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.2 Billion by the end of the ... Read More
-
Retinal Implants
... CAGR of 7.1% over the analysis period 2024-2030. Implantable Miniature Telescope, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$34.4 Million by the end of the ... Read More
-
Scaffold Technology
... CAGR of 7.0% over the analysis period 2024-2030. Hydrogels, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end of the analysis period. ... Read More
-
Urology Surgical Instruments
... at a CAGR of 7.7% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$13.5 Billion by the end ... Read More
-
Vaginitis Therapeutics
... CAGR of 7.6% over the analysis period 2024-2030. Anti-Bacterial Product, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Respiratory Protection Equipment
... at a CAGR of 6.4% over the analysis period 2024-2030. Air Purifying Respirators, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$15.3 Billion by the end ... Read More
-
Restorative Dentistry
... CAGR of 8.5% over the analysis period 2024-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$19.4 Billion by the end of the analysis ... Read More
-
Urothelial Cancer Drugs
... at a CAGR of 20.7% over the analysis period 2024-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$13.3 Billion by the end of the ... Read More
-
Intracranial Pressure (ICP) Monitoring Devices
... Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Invasive Devices, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.4 Billion ... Read More
-
Orthopedic Bone Cement
... at a CAGR of 4.9% over the analysis period 2024-2030. Polymethyl Methacrylate (PMMA) Cement, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$944.8 Million by the ... Read More
-
Breastfeeding Accessories
... CAGR of 6.6% over the analysis period 2024-2030. Breastmilk Storage & Feeding, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$974.4 Million by the end of ... Read More
Research Assistance
